血栓性抗脂综合征中的出血事件:患病率,严重程度和相关损害累计
Pedro Gaspar1,2, Prabal Mittal3,4, Hannah Cohen3,4
1Department of Internal Medicine, Hospital Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
Research and practice in thrombosis and haemostasis
|February 22, 2024
概括
抗凝固药物治疗的抗脂综合征 (APS) 患者患出血事件的风险很高. 近8%的患者因出血而遭受器官损伤,目前在APS损伤指数中没有考虑到这一点.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 抗脂综合征 (APS) 患者需要终身抗凝药,增加出血风险.
- 目前的APS损害指数不将出血事件纳入损害累计.
研究的目的:
- 描述APS患者出血事件的患病率,严重程度和由此产生的损伤.
- 评估出血对器官功能的影响以及器官切除的必要性.
主要方法:
- 根据2006年悉尼标准对血栓性APS患者的回顾性分析.
- 使用ISTH定义分类的出血事件 (主要与非主要).
- 损伤被定义为由于出血而导致的永久性器官功能下降或器官切除.
主要成果:
- 40.6%的患者在2412个患者年中经历了167次出血事件 (6.9次/100个PY).
- 严重出血发生在38.8%的病例中 (1.6事件/100年),中枢神经系统参与62.9%的病例.
- 流血导致7.6%的患者永久性器官损伤,主要来自中枢神经系统事件.
结论:
- 流血是APS患者的重要并发症,影响近40%的个体.
- 很大一部分出血事件导致永久性器官损伤,突显了当前APS损害评估中的差距.
相关概念视频
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K


